MX232591B - Procedimiento para tratar infecciones oculares con azitromicina - Google Patents

Procedimiento para tratar infecciones oculares con azitromicina

Info

Publication number
MX232591B
MX232591B MX9810124A MX9810124A MX232591B MX 232591 B MX232591 B MX 232591B MX 9810124 A MX9810124 A MX 9810124A MX 9810124 A MX9810124 A MX 9810124A MX 232591 B MX232591 B MX 232591B
Authority
MX
Mexico
Prior art keywords
azithromycin
procedure
eye infections
treat eye
treat
Prior art date
Application number
MX9810124A
Other languages
English (en)
Other versions
MXPA98010124A (es
Inventor
Imran Ahmed
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22074743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX232591(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MXPA98010124A publication Critical patent/MXPA98010124A/es
Publication of MX232591B publication Critical patent/MX232591B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
MX9810124A 1997-12-02 1998-12-01 Procedimiento para tratar infecciones oculares con azitromicina MX232591B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6725097P 1997-12-02 1997-12-02
US60/067,250 1997-12-02

Publications (2)

Publication Number Publication Date
MXPA98010124A MXPA98010124A (es) 1999-06-01
MX232591B true MX232591B (es) 2005-12-02

Family

ID=22074743

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9810124A MX232591B (es) 1997-12-02 1998-12-01 Procedimiento para tratar infecciones oculares con azitromicina

Country Status (11)

Country Link
EP (1) EP0925789B2 (es)
JP (1) JPH11240838A (es)
AT (1) ATE271390T1 (es)
BR (1) BR9805318A (es)
CA (1) CA2254682C (es)
CY (1) CY1105482T1 (es)
DE (1) DE69825128T3 (es)
DK (1) DK0925789T4 (es)
ES (1) ES2221127T5 (es)
MX (1) MX232591B (es)
PT (1) PT925789E (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861411B1 (en) 1997-12-02 2005-03-01 Pfizer, Inc. Method of treating eye infections with azithromycin
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
IT1313610B1 (it) * 1999-08-09 2002-09-09 S I F I Societa Ind Farmaceuti Processo per la preparazione di formulazioni acquose per uso oftalmico
DE10006560A1 (de) 2000-02-15 2001-08-23 Disetronic Licensing Ag Zweikomponentiger Kolbenstopfen
IL141438A0 (en) * 2000-02-23 2002-03-10 Pfizer Prod Inc Method of increasing the bioavailability and tissue penetration of azithromycin
EP1563850A3 (en) * 2000-02-23 2008-02-20 Pfizer Products Inc. Method of increasing the bioavailability and tissue penetration of azithromycin
FR2823441B1 (fr) * 2001-04-12 2004-09-10 Thea Lab Composition pharmaceutique a base de macrolides pour application locale en ophtalmologie et son procede de preparation
EP1652851A1 (en) 2001-05-22 2006-05-03 Pfizer Products Inc. New crystal form of Azithromycin
US7807802B2 (en) 2002-11-12 2010-10-05 Abbott Lab Polynucleotides for the amplification and detection of Chlamydia trachomatis and Neisseria gonorrhoeae
PL1691787T3 (pl) 2003-12-04 2008-11-28 Pfizer Prod Inc Sposób wytwarzania farmaceutycznych systemów wielocząstkowych
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
KR101130252B1 (ko) 2004-07-02 2012-03-26 와카모토 세이야꾸 가부시끼가이샤 아지스로마이신 함유 수성 의약 조성물 및 그 조제 방법
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
FR2884716B1 (fr) * 2005-04-22 2009-08-21 Thea Sa Lab Utilisation de l'azithromycine pour la fabrication d'un medicament destine au traitement des infections oculaires
WO2007074904A1 (ja) * 2005-12-28 2007-07-05 Wakamoto Pharmaceutical Co., Ltd. 水性医薬組成物
US20100247666A1 (en) * 2009-03-24 2010-09-30 Macleod Steven K Method for Preparing Suspensions of Low-Solubility Materials
US9775802B2 (en) 2009-03-24 2017-10-03 Bausch & Lomb Incorporated Method for preparing suspensions of low-solubility materials

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
JPH09503504A (ja) * 1993-10-01 1997-04-08 ザ、プロクター、エンド、ギャンブル、カンパニー 成人歯周炎の治療のためのアジトロマイシンの用途とこの用途のための局所組成物
US5610198A (en) † 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases
AU4399396A (en) * 1994-12-19 1996-07-10 Russinsky Limited Compounds
US5872104A (en) * 1994-12-27 1999-02-16 Oridigm Corporation Combinations and methods for reducing antimicrobial resistance
WO1996039995A1 (en) † 1995-06-07 1996-12-19 Southern Biosystems, Inc. High viscosity liquid controlled delivery system

Also Published As

Publication number Publication date
DE69825128T3 (de) 2010-05-06
ES2221127T3 (es) 2004-12-16
DE69825128D1 (de) 2004-08-26
EP0925789B1 (en) 2004-07-21
ES2221127T5 (es) 2009-11-10
CY1105482T1 (el) 2010-04-28
ATE271390T1 (de) 2004-08-15
DK0925789T3 (da) 2004-10-25
DE69825128T2 (de) 2005-07-28
JPH11240838A (ja) 1999-09-07
EP0925789B2 (en) 2009-06-17
CA2254682C (en) 2003-07-08
DK0925789T4 (da) 2009-07-13
PT925789E (pt) 2004-10-29
CA2254682A1 (en) 1999-06-02
BR9805318A (pt) 2000-04-11
EP0925789A1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
MX232591B (es) Procedimiento para tratar infecciones oculares con azitromicina
PT1117401E (pt) Composicoes antibioticas para o tratamento do olho
NO991974D0 (no) 5-HT1F agonister
PT1075837E (pt) Processo de preparacao de formulacoes aquosas para utilizacao oftalmicas
FI953180A0 (fi) Sokeritaudin komplikaatioiden hoitamiseen tarkoitetut koostumukset
BG99261A (en) Steroid glycosides for the treatment of hyperchlesterolemia
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
PT1056454E (pt) Utilizacao de compostos macrolido para o tratamento do glaucoma
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
ES2187845T3 (es) Solucion oftalmica vehiculo.
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
ES2163186T3 (es) Composicion que comprende mupirocina y clorhexidina.
ES2124327T3 (es) Derivados de sulfonamida aminometileno como inmunosupresores.
BR9914848A (pt) Composição e processo para o tratamento de distúrbios da retina externa
PT928183E (pt) Utilizacao de 1-hidroxilo-2-piridoneno para o tratamento da dermatite seborroica
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
DK0435177T3 (da) 4-Benzyl-5-phenyl-2,4-dihydro-3H-1,2,4-triazol-3-oner samt deres anvendelse som antikonvulsive midler
ID25478A (id) Agonis 5-ht1f
SE9200502D0 (sv) Novel antioxidants
ATE241640T1 (de) Fusidinsäure-derivate
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
ATE231001T1 (de) Verwendung von protein c inhibitor zur behandlung disseminierter intravasaler gerinnung (dic)
BR0214244A (pt) Uso de uma ascomicina
ES2086395T3 (es) Fosfolipidos para el tratamiento de esclerosis multiple.

Legal Events

Date Code Title Description
FG Grant or registration